Search companies or stocks...
Barinthus Biotherapeutics plc (BRNS) current market price $0.77; calculated gap vs modeled fair value is 1366.38%. The dollar intrinsic value estimate is available with Tickerplace Pro.
Confidence score is based on the magnitude of the gap vs the modeled estimate.
Fair value estimate
Unlock fair valueCurrent price
$0.77
Intrinsic value work for Barinthus Biotherapeutics plc anchors fair value on owner earnings and balance-sheet capacity, then places the current quote next to that estimate.
Versus historical valuation bands, BRNS can sit toward the lower or upper end of where this business has traded when profitability and growth were comparable — useful context before reading any single headline multiple.
Sector peers and macro rates still deserve a sanity check on the company page. The percentage gap on this snapshot is a model output, not a recommendation.
Barinthus Biotherapeutics plc (BRNS) current market price is $0.77, a calculated difference of 1366.4% versus modeled fair value. Tickerplace Pro unlocks the dollar intrinsic value estimate. This is a model output, not a recommendation.
Intrinsic value is an estimate of what BRNS shares may be worth based on fundamentals rather than today's price alone. See the valuation snapshot on this page for the latest model output. Tickerplace Pro unlocks the full dollar fair value estimate.
Tickerplace calculates BRNS's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to show the calculated gap.
BRNS’s calculated gap versus modeled fair value is 1366.4% at a market price of $0.77. A gap is a calculated difference between price and the model estimate, not a buy or sell conclusion. Confirm with ratios and financials on the company profile.
Peers for BRNS: open their calculated fair value vs price view.
